Diabetes Microvascular Complications

Bmj.com Donnelly et al. 320 (7241): 1062

In the UK prospective diabetes study, fatal cardiovascular events were 70 times more common than deaths from microvascular complications.

Tight blood pressure control and risk of macrovascular and

OBJECTIVE: To determine whether tight control of blood pressure prevents macrovascular and microvascular complications in patients with type 2 diabetes.

Microvascular Complications of Diabetes

The microvascular complications of diabetes encompass long term complications of diabetes affecting small blood vessels. These classically have included.

EMJA: 3: Preventing complications of diabetes

Microvascular complications are the major risk in type 1 diabetes, while macrovascular complications are the major cause of morbidity and mortality in type.

Diabetes, microvascular complications, and cardiovascular

Glucose is the driving force in microvascular complications of diabetes, yet the action of glucose alone seems inadequate and unable to account for the.

Complications of Diabetes

Description:, Diabetes can cause a range of long term complications that can be classified broadly as microvascular (relating to small blood vessels) or.

Diabetes, microvascular complications, and cardiovascular

Glucose is the driving force in microvascular complications of diabetes, yet the action of glucose alone seems inadequate and unable to account for the.

Diabetic Microvascular Complications - Medscape Resource Center

Diabetic microvascular complications, such as retinopathy, neuropathy, and nephropathy are becoming Diabetes is, of course, a disease of complications.

Microvascular Complications in Cystic Fibrosis-Related Diabetes

OBJECTIVE—The incidence of cystic fibrosis–related diabetes (CFRD) and the prevalence of diabetic microvascular complications were determined at the.

Diabetes, microvascular complications, and cardiovascular

Your browser may not have a PDF reader available. Google recommends visiting our text version of this document.The Journal of Clinical Investigation | October 2003 | Volume 112 | Number 7. Diabetes, microvascular complications,. and cardiovascular complications:.